ESC Professional Premium Access

Obesity and diabetes: key role for risk factor management

Event: ESC Congress 2022
Topic: Risk Factors and Prevention
Session type: Abstract Sessions
Date: 28 August 2022
Time: 09:00 - 09:40

Congress Session

3 presentations in this session

Effects of dapagliflozin on cardiovascular and kidney events by baseline eGFR and UACR in patients with type 2 diabetes mellitus: A patient-level pooled analysis of DECLARE-TIMI 58 and DAPA-CKD trials

Speaker: Doctor F. Moura (Boston, US)
Thumbnail

Relationship of obesity to mortality in 47 399 patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.

Speaker: Doctor T. Osadnik (Zabrze, PL)
Thumbnail

Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes

Speaker: Doctor S. Parveen (Copenhagen, DK)
Thumbnail

3 speakers from this session

Doctor Filipe Moura

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
1 follower

Doctor Tadeusz Osadnik

The Medical University of Silesia, Zabrze (Poland)
0 follower

Doctor Saaima Parveen

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

This platform is supported by

logo Novo Nordisk